SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-390283
Filing Date
2013-10-03
Accepted
2013-10-03 16:51:05
Documents
3
Period of Report
2013-11-08
Effectiveness Date
2013-10-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d604753ddef14a.htm DEF 14A 471793
2 GRAPHIC g604753g00y03.jpg GRAPHIC 2292
3 GRAPHIC g604753g79q84.jpg GRAPHIC 6593
  Complete submission text file 0001193125-13-390283.txt   485672
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 131134348
SIC: 2834 Pharmaceutical Preparations